FDA approves BeOne's (ONC) BRUKINSA tablet
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
U.S. FDA Approves Tablet Formulation of BeOne’s BRUKINSA® for All Approved Indications
June 11, 2025 4:05 PM EDTNew formulation provides patients with a simplified dosing experiencereducing pill burden and enhancing ease of administrationwhile preserving flexible dosing options
SAN CARLOS, Calif.--(BUSINESS WIRE)-- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and... More
